Literature DB >> 6190398

Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience.

G J Bosl, N L Geller, C Cirrincione, J Nisselbaum, D Vugrin, W F Whitmore, R B Golbey.   

Abstract

The serum values of alphafetoprotein, human chorionic gonadotropin, lactate dehydrogenase, and carcinoembryonic antigen in patients with metastatic testicular cancer were reviewed for the period 1972 to 1982. All values were obtained before chemotherapy was begun. Elevated values of alphafetoprotein were present in 47 percent of patients tested, of human chorionic gonadotropin in 60 percent, of lactate dehydrogenase in 64 percent, and of carcinoembryonic antigen in 11 percent. The frequency of elevated values of alphafetoprotein, human chorionic gonadotropin, and lactate dehydrogenase decreased during the study period. Inverse relations between elevated values of alphafetoprotein, human chorionic gonadotropin, and lactate dehydrogenase and both complete remission rate and survival rate were noted in some of the chemotherapy trials. Carcinoembryonic antigen was believed not to be useful as a marker in this disease. It is concluded that assays of alphafetoprotein, human chorionic gonadotropin, and lactate dehydrogenase are important both clinically and prognostically in patients with testicular cancer.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190398     DOI: 10.1016/0002-9343(83)91164-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

1.  Tumour markers in testicular cancer.

Authors:  P A Light
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

2.  A polymorphic variant of the lactate dehydrogenase B subunit in the rat.

Authors:  V Stolc
Journal:  Genetica       Date:  1987-05-15       Impact factor: 1.082

Review 3.  Optimal drug therapy in the treatment of testicular cancer.

Authors:  E R Priest; N J Vogelzang
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

4.  Analysis of a non-ras 21-kDa protein in patients with metastatic testicular germ-cell tumors.

Authors:  E Grundner-Culemann; C Bokemeyer; V Neubauer; C Shalitin; H J Schmoll; H Poliwoda; T Benter
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

5.  Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.

Authors:  Klaus-Peter Dieckmann; Hanna Simonsen-Richter; Magdalena Kulejewski; Petra Anheuser; Henrik Zecha; Hendrik Isbarn; Uwe Pichlmeier
Journal:  Biomed Res Int       Date:  2019-05-28       Impact factor: 3.411

6.  Racial differences in testicular cancer in the United States: descriptive epidemiology.

Authors:  Yang Li; Qi Lu; Yu Wang; Shuangge Ma
Journal:  BMC Cancer       Date:  2020-04-06       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.